KALA BIO, INC. Proceeds from Issuance of Secured Debt
KALA BIO, INC. (KALA) reported Proceeds from Issuance of Secured Debt of $2.73 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2019-11-07
- KALA BIO, INC. proceeds from issuance of secured debt for the quarter ending 2018-12-31 was $0.00.
- KALA BIO, INC. proceeds from issuance of secured debt for the quarter ending 2018-09-30 was $0.00.
- KALA BIO, INC. proceeds from issuance of secured debt for the quarter ending 2018-06-30 was $0.00.
- KALA BIO, INC. proceeds from issuance of secured debt for the quarter ending 2018-03-31 was $2.73M.
- KALA BIO, INC. proceeds from issuance of secured debt for fiscal 2018 was $2.73M, a 72.72% decline from fiscal 2017.
- KALA BIO, INC. proceeds from issuance of secured debt for fiscal 2017 was $10.00M.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 6 month | Proceeds from Issuance of Secured Debt 9 month | Proceeds from Issuance of Secured Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 derived: sum of 3 quarters · filed 2019-11-07 | $2.73M 10-K · filed 2019-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $2.73M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.73M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $2.73M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $10.00M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |